Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsCapital Bluecross Advantage Formulary Coverage | O…
    Ask Trek AI about this page
    CurrentCapital BluecrossPolicy N/A

    Capital Blue Cross Advantage Formulary

    Customize your policy alerts

    Sign up for all Capital Bluecross policy alerts

    Know when Capital Bluecross releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Advantage Formulary listing of covered prescription drugs, tier assignments, specialty designation, and utilization management indicators (Prior Authorization, Step Therapy, Quantity Level Limits, PHC, Limited Distribution). This fragment includes Anti‑Infective Agents (Penicillins/Cephalosporins/Macrolides) and supporting formulary development and program rules.

    Policy Summary
    PayerCapital Bluecross
    PolicyCapital Blue Cross Advantage Formulary
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJanuary 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization requests when the Prior Authorization column shows an indicator; verify step therapy, quantity limits, specialty dispensing and limited distribution status before prescribing.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes were reported in this brief.

    Anti‑InfectivesTherapeutic class included (sample)
    multipleProducts with PA/step/QLL/LD flags
    AccredoSpecialty pharmacy

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Jan 2026Document effective
    N/APolicy number

    Coverage summary & Applicability

    Coverage considerations and Utilization Management applicability

    Covered when ALL of the following are met:

    ALL of the following

    • The drug is a prescription medication FDA-approved as evidenced by an NDA, ANDA, or BLA (or coverage is otherwise required by law or the member’s specific benefit contract).
    • The prescribing provider has submitted any required documentation (e.g., diagnosis, prior treatments, supporting medical records) when the drug is subject to Utilization Management (UM) requirements such as Prior Authorization, Step Therapy, or Quantity Limits.

      Operational: documentation must support medical necessity for PA determinations.

    • If the drug is a specialty medication, it is dispensed through the plan’s specialty pharmacy (Accredo) when required by the plan, and limited distribution requirements are followed.
    • For drugs with available generic equivalents, coverage and member cost-sharing follow the plan’s generic substitution policy (mandatory, restricted, or voluntary) as applicable to the member’s benefit.
    • Maintenance drug supply limits (30-day standard; up to 90-day for select maintenance drugs per plan design) and specialty drug 30-day limits apply.
    • AND (specialty dispensing)

      • Specialty drugs are processed through the plan-designated specialty pharmacy (Accredo) when required.
      • Limited distribution specialty products must be obtained from approved dispensing pharmacies per manufacturer/plan restrictions.

    Utilization Management applicability

    • Prior Authorization (PA) may be required for specific drugs or indications; if required, the provider must obtain approval before the drug will be covered.

      PA requirements are indicated in the formulary where commonly applied.

    • Step Therapy (ST) may apply — trial of specified preferred agents required before coverage of non-preferred products.

      Failure to document trials may result in denial without PA override.

    • Quantity Limits (QL) may restrict the covered amount or dosing interval for certain agents (e.g., specialty drugs limited to 30-day supply).
    • Nonformulary exception process is available when a provider deems a non-formulary FDA-approved drug medically necessary prior to P&T review; submit nonformulary exception/PA requests with supporting information.

    This formulary excerpt is part of the Capital Blue Cross Advantage Formulary and reflects anti-infective agents with tiering applied. Utilization Management programs (Prior Authorization, Step Therapy, Quantity Limits) are defined and applied as noted in the formulary; specialty dispensing and limited distribution rules are enforced through the plan’s specialty pharmacy vendor (Accredo). Members and providers should consult the member’s specific benefit booklet for plan-level exceptions and supply limits.

    Utilization management & provider requirements

    Note
    Note
    Note
    Note
    Note

    Formulary drug entries and code groups

    AMOXICILLIN (TRIHYDRATE)NDCCovered
    amoxicillin chew tab 125 mgchewable tablet 125 mg
    amoxicillin chew tab 250 mgchewable tablet 250 mg
    amoxicillin cap 250 mgcapsule 250 mg
    amoxicillin cap 500 mgcapsule 500 mg
    amoxicillin for susp 125 mg/5mloral suspension 125 mg/5 ml
    amoxicillin for susp 200 mg/5mloral suspension 200 mg/5 ml
    amoxicillin for susp 250 mg/5mloral suspension 250 mg/5 ml
    amoxicillin for susp 400 mg/5mloral suspension 400 mg/5 ml
    amoxicillin tab 500 mgtablet 500 mg
    amoxicillin tab 875 mgtablet 875 mg
    AMOXICILLIN/CLAVULANATE (AUGMENTIN)NDCCovered
    amoxicillin & k clavulanate for susp 125-31.25 mg/5mloral suspension 125 mg/31.25 mg per 5 ml (Augmentin)
    amoxicillin & k clavulanate for susp 200-28.5 mg/5mloral suspension 200 mg/28.5 mg per 5 ml
    amoxicillin & k clavulanate for susp 250-62.5 mg/5mloral suspension 250 mg/62.5 mg per 5 ml (Augmentin)
    amoxicillin & k clavulanate for susp 400-57 mg/5mloral suspension 400 mg/57 mg per 5 ml
    amoxicillin & k clavulanate for susp 600-42.9 mg/5mloral suspension 600 mg/42.9 mg per 5 ml (Augmentin ES-600)
    amoxicillin & k clavulanate tab 250-125 mgtablet 250 mg/125 mg
    amoxicillin & k clavulanate tab 500-125 mgtablet 500 mg/125 mg (Augmentin)
    amoxicillin & k clavulanate tab 875-125 mgtablet 875 mg/125 mg
    AMOXICILLIN/CLAVULANATE P - amoxicillin & k clavulanate tab er 12hr 1000-62.5 mgextended-release tablet every 12 hours 1000 mg/62.5 mg
    PENICILLINS & RELATEDNDCCovered
    ampicillin cap 500 mgcapsule 500 mg
    penicillin v potassium for soln 125 mg/5mloral solution 125 mg/5 ml
    penicillin v potassium for soln 250 mg/5mloral solution 250 mg/5 ml
    penicillin v potassium tab 250 mgtablet 250 mg
    penicillin v potassium tab 500 mgtablet 500 mg
    dicloxacillin sodium cap 250 mgcapsule 250 mg
    dicloxacillin sodium cap 500 mgcapsule 500 mg
    CEPHALOSPORINSNDCCovered
    CEFACLOR - cefaclor cap 250 mgcapsule 250 mg
    CEFACLOR - cefaclor cap 500 mgcapsule 500 mg
    CEFACLOR - cefaclor for susp 250 mg/5mloral suspension 250 mg/5 ml
    CEFACLOR ER - cefaclor monohydrate tab er 12hr 500 mgextended-release tablet 500 mg
    CEFADROXIL - cefadroxil tab 1 gmtablet 1 g
    cefadroxil cap 500 mgcapsule 500 mg
    cefadroxil for susp 250 mg/5mloral suspension 250 mg/5 ml
    cefadroxil for susp 500 mg/5mloral suspension 500 mg/5 ml
    cefdinir cap 300 mgcapsule 300 mg
    cefdinir for susp 125 mg/5mloral suspension 125 mg/5 ml
    1–10 of 29
    1/3
    MACROLIDES & LINCOSAMIDESNDCCovered
    azithromycin for susp 100 mg/5mloral suspension 100 mg/5 ml (Zithromax)
    azithromycin for susp 200 mg/5mloral suspension 200 mg/5 ml (Zithromax)
    azithromycin tab 150 mgtablet 150 mg (Zithromax)
    azithromycin tab 250 mgtablet 250 mg (Zithromax)
    azithromycin tab 500 mgtablet 500 mg (Zithromax)
    azithromycin tab 600 mgtablet 600 mg (Zithromax)
    clarithromycin for susp 125 mgoral suspension 125 mg
    clarithromycin tab er 24hr 500 mgextended-release tablet 500 mg
    clarithromycin tab 250 mgtablet 250 mg (Biaxin)
    clarithromycin tab 500 mgtablet 500 mg (Biaxin)
    1–10 of 18
    1/2
    FIDAXOMICINNDCCovered
    DIFICID - fidaxomicin for susp 40 mg/mloral suspension 40 mg/ml
    DIFICID - fidaxomicin tab 200 mgtablet 200 mg
    fidaxomicin tab 200 mgtablet 200 mg (Dificid)
    TETRACYCLINES & SARECYCLINENDCCovered
    tetracycline hcl captetracycline HCl capsules (various strengths)
    SEYSARA - sarecycline hcl tab 60 mgtablet 60 mg (base equivalent)
    SEYSARA - sarecycline hcl tab 100 mgtablet 100 mg (base equivalent)
    SEYSARA - sarecycline hcl tab 150 mgtablet 150 mg (base equivalent)
    FLUOROQUINOLONES & OTHER ORALSNDCCovered
    CIPROciprofloxacin oral (suspension, tablets)
    levofloxacinlevofloxacin oral (solution, tablets)
    moxifloxacinmoxifloxacin tablets
    OFLOXACINofloxacin oral formulations
    AMINOGLYCOSIDES & INHALED TOBRAMYCIN GROUPNDCCovered
    AMINOGLYCOSIDES groupclass-level aminoglycosides
    ARIKAYCEamikacin liposome inhalation suspension (Arikayce)
    BETHKIStobramycin inhalation solution (Bethkis)
    KITABIS PAKtobramycin inhalation solution kit (Kitabis Pak)
    TOBItobramycin inhalation solution (Tobi)
    TOBI PODHALER - tobramycin inhal cap 28 mgtobramycin inhalation capsules 28 mg (Tobi Podhaler)
    TOBRAMYCIN (generic)tobramycin generic formulations
    tobramycin nebu soln 300 mg/5mlnebulization solution 300 mg/5 ml
    AMINOGLYCOSIDE ORAL/OTHERNDCCovered
    neomycin sulfate tabneomycin sulfate tablets
    ANTIFUNGALSNDCCovered
    fluconazole tab 50 mgtablet 50 mg
    fluconazole tab 100 mgtablet 100 mg
    fluconazole tab 150 mgtablet 150 mg
    fluconazole tab 200 mgtablet 200 mg
    griseofulvin microsize susp 125 mg/5mloral suspension 125 mg/5 ml
    griseofulvin ultramicrosize tab 125 mgtablet 125 mg (ultramicrosize)
    griseofulvin ultramicrosize tab 250 mgtablet 250 mg (ultramicrosize)
    itraconazole cap 100 mgcapsule 100 mg (Sporanox)
    itraconazole oral soln 10 mg/mloral solution 10 mg/ml (Sporanox)
    ketoconazole tab 200 mgtablet 200 mg
    1–10 of 20
    1/2
    ANTIVIRALS & HEPATITIS/OTHER ANTIVIRALSNDCCovered
    ANTIVIRALS (class-level header)class-level header
    abacavir sulfate soln 20 mg/mloral solution 20 mg/ml (Ziagen)
    abacavir sulfate tab 300 mgtablet 300 mg (Ziagen)
    abacavir sulfate-lamivudine tab 600-300 mgcombination tablet (Epzicom)
    acyclovir cap 200 mgcapsule 200 mg (Zovirax)
    acyclovir susp 200 mg/5mloral suspension 200 mg/5 ml
    acyclovir tab 400 mgtablet 400 mg
    acyclovir tab 800 mgtablet 800 mg
    adefovir dipivoxil tab 10 mgtablet 10 mg (Hepsera)
    emtricitabine-rilpivirine-tenofovir df tab 200-25-300 mgComplera combination tablet
    1–10 of 21
    1/3
    ANTIPARASITIC/ANTIMALARIALS & MISC INFECTIOUS DISEASENDCCovered
    chloroquine phosphate tab 500 mgchloroquine phosphate tablet 500 mg
    valacyclovir hcl tab 500 mgvalacyclovir tablet 500 mg (Valtrex)
    mebendazole chew tab 100 mgmebendazole chewable tablet 100 mg (Emverm)
    praziquantel tab 600 mgpraziquantel tablet 600 mg
    ivermectin tab 3 mgivermectin tablet 3 mg (Stromectol)
    atovaquone susp 750 mg/5 mlatovaquone suspension 750 mg/5 ml (Mepron)
    tafenoquine succinate tab 150 mgtafenoquine tablet 150 mg (Krintafel)
    atovaquone-proguanil hcl tab 62.5-25 mgMalarone 62.5 mg/25 mg
    atovaquone-proguanil hcl tab 250-100 mgMalarone 250 mg/100 mg
    mefloquine hcl tab 250 mgmefloquine tablet 250 mg
    OTHER NOTABLE ANTIMICROBIALS & UTI AGENTSNDCCovered
    clindamycin hcl cap 75 mgclindamycin capsule 75 mg (Cleocin)
    vancomycin hcl for oral soln 25 mg/mloral solution 25 mg/ml (Firvanq)
    vancomycin hcl for oral soln 50 mg/mloral solution 50 mg/ml
    vancomycin hcl cap 125 mgcapsule 125 mg (Vancocin)
    vancomycin hcl cap 250 mgcapsule 250 mg (Vancocin)
    fosfomycin tromethamine powd pack 3 gmpowder packet 3 g (Monurol)
    nitrofurantoin monohydrate macrocrystalline cap 100 mgcap 100 mg (Macrobid)
    nitrofurantoin macrocrystalline cap 25 mgcap 25 mg (Macrodantin)
    nitrofurantoin macrocrystalline cap 50 mgcap 50 mg (Macrodantin)
    STOREFRONT VACCINES & PUBLIC HEALTHNDCCovered
    ENGERIX-B hepatitis B vaccine susp 20 mcg/mlEngerix-B suspension 20 mcg/ml
    FLUAD 2025-2026 influenza vaccineFluad seasonal influenza 2025-2026
    AFLURIA 2025-2026Afluria seasonal influenza 2025-2026
    COMIRNATY 2025-26 variantsComirnaty COVID-19 vaccine 2025-26 variants
    GARDASIL 9Gardasil 9 HPV vaccine
    PNEUMOVAX 23Pneumovax 23 pneumococcal vaccine
    PREVNAR 20Prevnar 20 pneumococcal conjugate vaccine
    SHINGRIXShingrix herpes zoster vaccine
    VARIVAXVarivax varicella vaccine
    SELECTED MISCELLANEOUS INFECTIOUS DISEASE AGENTS & OTHERSNDCCovered
    linezolid tab 600 mglinezolid tablet 600 mg (Zyvox)
    linezolid susp 100 mg/5mloral suspension 100 mg/5 ml (Zyvox)
    rifaximin tab 200 mgrifaximin tablet 200 mg (Xifaxan)
    rifaximin tab 550 mgrifaximin tablet 550 mg (Xifaxan)
    metronidazole tab 250 mgmetronidazole tablet 250 mg (Flagyl)
    metronidazole tab 500 mgmetronidazole tablet 500 mg (Flagyl)
    tedizolid phosphate tab 200 mgtedizolid phosphate tablet 200 mg (Sivextro)
    sulfamethoxazole-trimethoprim susp 200-40 mg/5 mloral suspension 200 mg/40 mg per 5 ml
    sulfamethoxazole-trimethoprim tab 400-80 mgtablet 400 mg/80 mg (Bactrim)
    sulfamethoxazole-trimethoprim tab 800-160 mgtablet 800 mg/160 mg (Bactrim DS)
    1–10 of 12
    1/2
    ANTIBIOTIC BRANDS/KEY TRADE NAMES (INDEX)mixed
    AUGMENTINamoxicillin-clavulanate preparations listed above
    AUGMENTIN ES-600amoxicillin-clavulanate 600-42.9 mg/5 ml suspension and related ES formulations
    ZITHROMAXazithromycin formulations listed above
    ZITHROMAX TRI-PAKazithromycin 500 mg tri-pack
    BAXDELAdelafloxacin oral formulations
    BETHKIStobramycin inhalation solution (Bethkis)
    TOBI PODHALERtobramycin inhalation capsules 28 mg
    TOBI PODHALER - duplicatedZithromax Tri-Pak and Seysara also indexed
    ADDITIONAL INDEX ENTRIESmixed
    PAXLOVIDnirmatrelvir-ritonavir (indexed)
    RIBAVIRINribavirin formulations
    VALGANCICLOVIR HCL soln 50 mg/mlValganciclovir oral solution 50 mg/ml (Valcyte)
    VALGANCICLOVIR HCL tab 450 mgValganciclovir tablet 450 mg (Valcyte)
    BENZNIDAZOLE tab 12.5 mgbenznidazole tablet 12.5 mg
    FOSFOMYCIN tromethamine powd pack 3 gmMonurol

    Initial therapy criteria

    Examples: products that may require PA / Step Therapy / Limited Distribution

    Applicable codes and product groups

    Revision history

    Policy Summary
    PayerCapital Bluecross
    PolicyCapital Blue Cross Advantage Formulary
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJanuary 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization requests when the Prior Authorization column shows an indicator; verify step therapy, quantity limits, specialty dispensing and limited distribution status before prescribing.
    SourceLink
    On This Page
    Coverage summary & ApplicabilityUtilization management & provider requirementsFormulary drug entries and code groupsInitial therapy criteriaBackground & definitionsExamples: products that may require PA / Step Therapy / Limited DistributionEvidence & supporting notesApplicable codes and product groupsRevision history